Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data

被引：0
|
作者：
Samuel Mon-Wei Yu
Jeremy S. Leventhal
Paolo Cravedi
机构：
[1] Icahn School of Medicine at Mount Sinai,Department of Medicine, Translational Transplant Research Center
[2] White Plains Hospital,Division of Nephrology
来源：
Journal of Nephrology | 2021年 / 34卷
关键词：
Sodium glucose co-transporter 2; Diabetic kidney disease; Proximal tubule; Tubuloglomerular feedback; Autophagy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：629 / 631
页数：2
相关论文
共 50 条
  • [31] ARNI and SGLT2i: a promising association to be used with caution
    Andrea Herbst
    Francesco Orso
    Marta Migliorini
    Simona Virciglio
    Silvia Tognelli
    Viola Camartini
    Alessandra Pratesi
    Francesco Fattirolli
    Niccolò Marchionni
    Andrea Ungar
    Samuele Baldasseroni
    Journal of Geriatric Cardiology, 2020, 17 (11) : 728 - 732
  • [32] ARNI and SGLT2i: a promising association to be used with caution
    Andrea Herbst
    Francesco Orso
    Marta Migliorini
    Simona Virciglio
    Silvia Tognelli
    Viola Camartini
    Alessandra Pratesi
    Francesco Fattirolli
    Niccol Marchionni
    Andrea Ungar
    Samuele Baldasseroni
    Journal of Geriatric Cardiology, 2020, 17 (11) : 728 - 732
  • [33] Class effects of SGLT2 inhibitors (SGLT2i) in the heart: SGLT2i inhibit NHE, reduce [Na+]c and activate vasorelaxation in isolated mouse cardiomyocytes/hearts
    Uthman, L.
    Baartscheer, A.
    Bleijlevens, B.
    Schumacher, C. A.
    Fiolet, J. W. T.
    Koeman, A.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Zuurbier, C. J.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 109 : 59 - 59
  • [34] A PATIENT WITH UNEXPLAINED ERYTHROCYTOSIS. IS THERE AN SGLT2 INHIBITOR (SGLT2I) ON THE MEDICATION LIST?
    Wagar, Danish
    Leehey, David
    Vellanki, Kavitha
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S62 - S62
  • [35] Timing of SGLT2i initiation after acute myocardial infarction
    Dirk von Lewinski
    Ewald Kolesnik
    Faisal Aziz
    Martin Benedikt
    Norbert J. Tripolt
    Markus Wallner
    Peter N. Pferschy
    Friederike von Lewinski
    Nora Schwegel
    Rury R. Holman
    Abderrahim Oulhaj
    Deddo Moertl
    Jolanta Siller-Matula
    Harald Sourij
    Cardiovascular Diabetology, 22
  • [36] INDEPENDENT EFFECT OF SGLT2I ON DIASTOLIC FUNCTION IN HFREF POPULATION
    Stracqualursi, M.
    Nemola, G.
    Moscardelli, S.
    Santangelo, G.
    Buratti, S.
    Losito, M.
    Bursi, F.
    Guazzi, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26
  • [37] Safety and Efficacy of SGLT2i Post Orthotopic Heart Transplantation
    Sundaravel, S.
    Zolty, R.
    Stoller, D.
    Lowes, B.
    Lundgren, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S130 - S130
  • [38] SGLT2i Use in Pediatric Heart Failure: Multicenter Study
    Butts, R.
    Nandi, D.
    Hong, B.
    Lorts, A.
    Profita, E.
    Spinner, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S149 - S149
  • [39] Impact of SGLT2i Use on Functional Capacity in Heart Failure
    Jang, J.
    Nativi-Nicolau, J.
    Yip, D.
    Patel, P.
    Leoni-Moreno, J.
    Goswami, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S333 - S333
  • [40] SGLT2i Prescribers Among CKD Patients: Trends in Real-World Data (RWD)
    Stavas, Joseph
    Butler, Emily L.
    Abdelhadi, Jenna
    Zhang, Tancy C.
    Rubens, Lexie
    Irwin, Debra E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 573 - 573
12345